Clinical Trials Browser

Observational × Tegafur × Gastrointestinal × Clear all

NCT04856761 2022-08-18

A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Recurrence, Cholangiocarcinoma

NCT00898846 2016-09-28

Identifying Prognostic Factors in Patients Receiving Tegafur-Uracil for Stage II Colon Cancer That Was Completely Removed By Surgery

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms